Back Pain Results, page-25

It's a fair point that Teva wouldn't want MSB to starve. However, I think it's perhaps unlikely that they would pony up some $$ outside a contracted milestone payment

But you and I don't know what the contract says do we? And this is an award winning agreement, so you can safely assume it is not like the usual agreement, surely?

You assume that payments on completion of another stage, but stage 3 is the big kahuna. And stage 3 is a scaled up version of stage 2 and where most of the costs are incurred. So you can have other stages such as completion of recruitment, completion of dosage, etc.

Teva letting MSB starve of funds would be a colossal error. It's would be the equivalent of shooting themselves in the foot.

Not going to happen, on the grounds of simple logic and commercial reality. IMO.

I agree with Roberts about the cause of the lower SP being sentiment related. It's also about the colossal shift to dividend paying stocks.